181 related articles for article (PubMed ID: 32151015)
1. Optimization of Drug Permeation from 8% Ciclopirox Cyclodextrin/Poloxamer-Soluble Polypseudorotaxane-Based Nail Lacquers.
Cutrín-Gómez E; Conde-Penedo A; Anguiano-Igea S; Gómez-Amoza JL; Otero-Espinar FJ
Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32151015
[TBL] [Abstract][Full Text] [Related]
2. Effect of Penetration Enhancers on Drug Nail Permeability from Cyclodextrin/Poloxamer-Soluble Polypseudorotaxane-Based Nail Lacquers.
Cutrín-Gómez E; Anguiano-Igea S; Delgado-Charro MB; Gómez-Amoza JL; Otero-Espinar FJ
Pharmaceutics; 2018 Dec; 10(4):. PubMed ID: 30551601
[TBL] [Abstract][Full Text] [Related]
3. Effect on Nail Structure and Transungual Permeability of the Ethanol and Poloxamer Ratio from Cyclodextrin-Soluble Polypseudorotaxanes Based Nail Lacquer.
Cutrín-Gómez E; Anguiano-Igea S; Delgado-Charro MB; Gómez-Amoza JL; Otero-Espinar FJ
Pharmaceutics; 2018 Sep; 10(3):. PubMed ID: 30208659
[TBL] [Abstract][Full Text] [Related]
4. Thermogelling hydrogels of cyclodextrin/poloxamer polypseudorotaxanes as aqueous-based nail lacquers: application to the delivery of triamcinolone acetonide and ciclopirox olamine.
Nogueiras-Nieto L; Begoña Delgado-Charro M; Otero-Espinar FJ
Eur J Pharm Biopharm; 2013 Apr; 83(3):370-7. PubMed ID: 23201053
[TBL] [Abstract][Full Text] [Related]
5. Hydrosoluble medicated nail lacquers: in vitro drug permeation and corresponding antimycotic activity.
Monti D; Saccomani L; Chetoni P; Burgalassi S; Senesi S; Ghelardi E; Mailland F
Br J Dermatol; 2010 Feb; 162(2):311-7. PubMed ID: 19886884
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the promoting effect of soluble cyclodextrins in drug nail penetration.
Gómez EC; Anguiano Igea S; Gómez Amoza JL; Otero Espinar FJ
Eur J Pharm Sci; 2018 May; 117():270-278. PubMed ID: 29501459
[TBL] [Abstract][Full Text] [Related]
7. Development of ciclopirox nail lacquer with enhanced permeation and retention.
Thapa RK; Choi JY; Go TG; Kang MH; Han SD; Jun JH; Son MW; Yong CS; Kim JO
Arch Pharm Res; 2016 Jul; 39(7):953-9. PubMed ID: 27306785
[TBL] [Abstract][Full Text] [Related]
8. Optimized Ciclopirox-Based Eudragit RLPO Nail Lacquer: Effect of Endopeptidase Enzyme as Permeation Enhancer on Transungual Drug Delivery and Efficiency Against Onychomycosis.
Khattab A; Shalaby S
AAPS PharmSciTech; 2018 Apr; 19(3):1048-1060. PubMed ID: 29138987
[TBL] [Abstract][Full Text] [Related]
9. A preformulation strategy for the selection of penetration enhancers for a transungual formulation.
Palliyil B; Lebo DB; Patel PR
AAPS PharmSciTech; 2013 Jun; 14(2):682-91. PubMed ID: 23572254
[TBL] [Abstract][Full Text] [Related]
10. In vitro permeation and penetration of ciclopirox olamine from poloxamer 407-based formulations--comparison of isolated human stratum corneum, bovine hoof plates and keratin films.
Täuber A; Müller-Goymann CC
Int J Pharm; 2015 Jul; 489(1-2):73-82. PubMed ID: 25895717
[TBL] [Abstract][Full Text] [Related]
11. In vitro transungual permeation of ciclopirox from a hydroxypropyl chitosan-based, water-soluble nail lacquer.
Monti D; Saccomani L; Chetoni P; Burgalassi S; Saettone MF; Mailland F
Drug Dev Ind Pharm; 2005 Jan; 31(1):11-7. PubMed ID: 15704853
[TBL] [Abstract][Full Text] [Related]
12. Ciclopirox Hydroxypropyl Chitosan (HPCH) Nail Lacquer: A Review of Its Use in Onychomycosis.
Piraccini BM; Iorizzo M; Lencastre A; Nenoff P; Rigopoulos D
Dermatol Ther (Heidelb); 2020 Oct; 10(5):917-929. PubMed ID: 32705532
[TBL] [Abstract][Full Text] [Related]
13. A randomized comparison of nail surface remanence of three nail lacquers, containing amorolfine 5%, ciclopirox 8% or tioconazole 28%, in healthy volunteers.
Sidou F; Soto P
Int J Tissue React; 2004; 26(1-2):17-24. PubMed ID: 15573688
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the antifungal efficacy of terbinafine hydrochloride and ciclopirox olamine containing formulations against the dermatophyte Trichophyton rubrum in an infected nail plate model.
Täuber A; Müller-Goymann CC
Mol Pharm; 2014 Jul; 11(7):1991-6. PubMed ID: 24490976
[TBL] [Abstract][Full Text] [Related]
15. Amorolfine vs. ciclopirox - lacquers for the treatment of onychomycosis.
Tabara K; Szewczyk AE; Bienias W; Wojciechowska A; Pastuszka M; Oszukowska M; Kaszuba A
Postepy Dermatol Alergol; 2015 Feb; 32(1):40-5. PubMed ID: 25821426
[TBL] [Abstract][Full Text] [Related]
16. Polyurethanes as New Excipients in Nail Therapeutics.
Valdes BSG; Serro AP; Marto J; Santos RGD; Gómez EC; Otero-Espinar FJ; Bordado JM; Ribeiro HM
Pharmaceutics; 2018 Dec; 10(4):. PubMed ID: 30551686
[TBL] [Abstract][Full Text] [Related]
17. Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis.
Gupta AK; Fleckman P; Baran R
J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S70-80. PubMed ID: 11051136
[TBL] [Abstract][Full Text] [Related]
18. Dermatopharmacology of ciclopirox nail lacquer topical solution 8% in the treatment of onychomycosis.
Bohn M; Kraemer KT
J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S57-69. PubMed ID: 11051135
[TBL] [Abstract][Full Text] [Related]
19. Antifungal activity, experimental infections and nail permeation of an innovative ciclopirox nail lacquer based on a water-soluble biopolymer.
Togni G; Mailland F
J Drugs Dermatol; 2010 May; 9(5):525-30. PubMed ID: 20480796
[TBL] [Abstract][Full Text] [Related]
20. Ciclopirox delivery into the human nail plate using novel lipid diffusion enhancers.
Hafeez F; Hui X; Selner M; Rosenthal B; Maibach H
Drug Dev Ind Pharm; 2014 Jun; 40(6):838-44. PubMed ID: 23600655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
